Development of Cell-Based Tuberculosis Vaccines: Genetically Modified Dendritic Cell Vaccine Is a Much More Potent Activator of CD4 and CD8 T Cells Than Peptide- or Protein-Loaded Counterparts
Titel:
Development of Cell-Based Tuberculosis Vaccines: Genetically Modified Dendritic Cell Vaccine Is a Much More Potent Activator of CD4 and CD8 T Cells Than Peptide- or Protein-Loaded Counterparts
Auteur:
Malowany, Janet I. McCormick, Sarah Santosuosso, Michael Zhang, Xizhong Aoki, Naoko Ngai, Patricia Wang, Jun Leitch, Jaina Bramson, Jonathan Wan, Yonghong Xing, Zhou